Coming Soon

Chain Biotech specializes in developing innovative biotechnological solutions, particularly focusing on advancing synthetic biology and the commercialization of bioprocesses for various applications, including pharmaceuticals and agriculture.
Spinout Company
Public Funding Received
2022-05-01
Bridging the oral vaccine efficacy gap for childhood diarrhoeal disease
Collaborative R&D
2019-12-01
Advanced Vaccine Delivery to the Gut
Collaborative R&D
2019-10-01
University of Reading and CHAIN Biotechnology Limited
Knowledge Transfer Partnership
2019-04-01
Mucosal delivery of Clostridium spores encoding recombinant overlapping peptides of HPV antigen as therapeutic vaccines for cervical cancer
Feasibility Studies
2018-12-01
MICRoMED – Microbial Restoration of intestinal Metabolite balance for type 2 Diabetes 11915 "The microbial population in the gut and the metabolites it produces play an important role in health. Metabolites have a significant signalling role
Feasibility Studies
2018-02-01
Anaerobic Bacterial Spore Therapeutics and their Manufacture
Feasibility Studies
2017-09-01
Developing Clostridium as a Novel Secretion System for Therapeutic Peptides
Collaborative R&D
2017-08-01
Butanediol Production in Clostridia
Feasibility Studies
2016-04-01
Engineering Bacteria to Convert Methane into Poly Unsaturated Fatty Acids (PUFA)
Feasibility Studies
2015-08-01
Chiral Chemical Synthesis in Clostridia
Feasibility Studies
2015-06-01
Redesigning Metabolic Circuits for Speciality Chemical Production
Feasibility Studies